ShareHope Medicine Co., Ltd. (TPEX:8403)
22.60
+0.15 (0.67%)
At close: Mar 27, 2026
ShareHope Medicine Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,339 | 1,460 | 1,383 | 1,535 | 1,557 |
Short-Term Investments | 226.27 | - | - | - | - |
Trading Asset Securities | 12.78 | 10.61 | 10.46 | 10.34 | 10.28 |
Cash & Short-Term Investments | 1,578 | 1,470 | 1,393 | 1,546 | 1,567 |
Cash Growth | 7.31% | 5.51% | -9.84% | -1.40% | -8.67% |
Accounts Receivable | 1,172 | 1,241 | 1,388 | 1,236 | 1,092 |
Other Receivables | 52.03 | 319.42 | 74.08 | 82.1 | 149.28 |
Receivables | 1,224 | 1,560 | 1,462 | 1,318 | 1,242 |
Inventory | 291.86 | 292.26 | 296.47 | 272.54 | 290.64 |
Prepaid Expenses | 35.81 | 36.92 | 45.14 | 48.51 | 43.89 |
Other Current Assets | 2.44 | 32.94 | 42.09 | 8 | 11.64 |
Total Current Assets | 3,132 | 3,392 | 3,240 | 3,192 | 3,155 |
Property, Plant & Equipment | 1,726 | 1,840 | 2,084 | 2,156 | 1,086 |
Long-Term Investments | 595.61 | 874.6 | 911.23 | 832.93 | 654.67 |
Goodwill | - | 165.52 | 165.52 | 165.52 | 165.52 |
Other Intangible Assets | 310.07 | 156.6 | 171.61 | 177.16 | 172.22 |
Long-Term Accounts Receivable | - | 15.97 | 24.63 | 11.88 | 19.64 |
Long-Term Deferred Tax Assets | 48.7 | 14.44 | 12.98 | 10.98 | 14 |
Other Long-Term Assets | 802.77 | 641.91 | 835.61 | 831.01 | 845.15 |
Total Assets | 6,615 | 7,102 | 7,446 | 7,378 | 6,113 |
Accounts Payable | 688.62 | 685.08 | 842.29 | 802.79 | 650.78 |
Accrued Expenses | - | 185.39 | 173.74 | 178.26 | 167.25 |
Short-Term Debt | 431.37 | 487.9 | 462.37 | 361.15 | 331.08 |
Current Portion of Long-Term Debt | - | 185.16 | 121.21 | 31.75 | 33.07 |
Current Portion of Leases | 95.31 | 109.78 | 140.85 | 118.5 | 119.2 |
Current Income Taxes Payable | 18.98 | 24.43 | 52.45 | 58.14 | 68.66 |
Current Unearned Revenue | 17.26 | 48.82 | 12.66 | 5.53 | 7.28 |
Other Current Liabilities | 312.15 | 133.44 | 159.41 | 173.44 | 94.52 |
Total Current Liabilities | 1,564 | 1,860 | 1,965 | 1,730 | 1,472 |
Long-Term Debt | 811.68 | 825.24 | 1,006 | 967.62 | 124.46 |
Long-Term Leases | 373.45 | 379.2 | 449.91 | 526.58 | 600.98 |
Pension & Post-Retirement Benefits | - | 7.27 | 8.23 | 7.97 | 9.14 |
Long-Term Deferred Tax Liabilities | 11.54 | 29.2 | 33.24 | 17.82 | 14.19 |
Other Long-Term Liabilities | 22.82 | 19.76 | 28.05 | 29.21 | 8.93 |
Total Liabilities | 2,783 | 3,121 | 3,490 | 3,279 | 2,230 |
Common Stock | 1,376 | 1,311 | 1,260 | 1,200 | 1,143 |
Additional Paid-In Capital | 1,151 | 1,150 | 1,156 | 1,265 | 1,267 |
Retained Earnings | 1,060 | 1,049 | 949.01 | 947.9 | 764.26 |
Comprehensive Income & Other | -143.31 | 47 | 122.65 | 6.43 | -26.14 |
Total Common Equity | 3,444 | 3,557 | 3,488 | 3,419 | 3,149 |
Minority Interest | 388.51 | 424.17 | 467.52 | 679.74 | 734.49 |
Shareholders' Equity | 3,832 | 3,981 | 3,955 | 4,099 | 3,883 |
Total Liabilities & Equity | 6,615 | 7,102 | 7,446 | 7,378 | 6,113 |
Total Debt | 1,712 | 1,987 | 2,180 | 2,006 | 1,209 |
Net Cash (Debt) | -134.08 | -517.02 | -786.54 | -460.08 | 358.67 |
Net Cash Growth | - | - | - | - | -52.09% |
Net Cash Per Share | -0.97 | -3.74 | -5.69 | -3.32 | 2.58 |
Filing Date Shares Outstanding | 137.48 | 137.64 | 137.64 | 137.64 | 137.64 |
Total Common Shares Outstanding | 137.48 | 137.64 | 137.64 | 137.64 | 137.64 |
Working Capital | 1,569 | 1,532 | 1,275 | 1,463 | 1,683 |
Book Value Per Share | 25.05 | 25.84 | 25.34 | 24.84 | 22.88 |
Tangible Book Value | 3,134 | 3,235 | 3,151 | 3,077 | 2,811 |
Tangible Book Value Per Share | 22.79 | 23.50 | 22.89 | 22.35 | 20.42 |
Land | - | 651.35 | 665.25 | 668.58 | 17.23 |
Buildings | - | 538.74 | 530.33 | 550.96 | 36.78 |
Machinery | - | 725.95 | 711.44 | 676.28 | 681.64 |
Construction In Progress | - | - | - | 85.87 | - |
Leasehold Improvements | - | 211.12 | 230.22 | 216.17 | 214.44 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.